TAIHO PHARMA NETHERLANDS BV

Italy

All drugs from this manufacturer

  • LYTGOBI

    It is used for the treatment of adults with bile duct cancer (cholangiocarcinoma) that has spread or cannot be surgically removed, in patients who have already received previous treatment and who present a certain type of abnormal 'FGFR' protein.

    Dosage form: tablets, film-coated

    Active substance Dosage
    futibatinib -

    ATC: L01EN04